ACM
PFE icon

Andina Capital Management’s Pfizer PFE Stock Holding History

Andina Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,889
Closed -$236K – 155
2024
Q4 		$236K Sell
8,889
-1,264
-12% -$34.3K 0.19% 94
2024
Q3 		$294K Buy
10,153
+118
+1% +$3.44K 0.22% 86
2024
Q2 		$281K Buy
+10,035
New +$276K 0.21% 94

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Andina Capital Management's PFE Position: Q1 2025 in Review

Andina Capital Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 8,889 shares — an estimated $236K sold.

Andina Capital Management first reported a position in PFE in Q2 2024 and held it in 3 quarters. The position peaked at $294K in Q3 2024. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Andina Capital Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Andina Capital Management sold 8,889 Pfizer shares in Q1 2025, an estimated $236K.
  • Andina Capital Management first reported a position in Pfizer in Q2 2024 and held it in 3 quarters.
  • Andina Capital Management's Pfizer position peaked at $294K in Q3 2024.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Andina Capital Management's 13F filing for Q1 2025, filed 14 May 2025.